Relmada Therapeutics, Inc. RLMD Effective Income Tax Rate Reconciliation Permanent Trueups

Effective Income Tax Rate Reconciliation Permanent Trueups at other companies

ZumiezZUMZ

6%+5.7pp

Community Health SystemsCYH

$750K-57.1%

Community Health SystemsCYH

0.4%+0.2pp

Quantum Computing Inc.QUBT

0%—

AeroVironmentAVAV

3.7%+3.1pp

Evolution Metals & Technologies Corp. EMAT

-14.7%-1.4pp

Operating income-$19.5M-6.8%

Net income-$19.1M-8.5%

EPS (diluted)-$0.22+62.1%

Cash & equivalents$9.8M+750%

Total debt$104.1M-40.4%

Total equity$218.7M+875%

Total assets$235.4M+750%

Operating cash flow-$15.1M+16.6%

Market cap$677.17M+2,907%

Return on equity-48.8%-20.0pp

Debt / equity0.9×0.0×

Current ratio18.3×+13.0×

Reported directly by Relmada Therapeutics, Inc. in its filing.

Tagged under the XBRL concept rlmd:EffectiveIncomeTaxRateReconciliationPermanentTrueups.

The official record: Relmada Therapeutics, Inc.’s 10-K, filed March 19, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is Relmada Therapeutics, Inc.'s effective income tax rate reconciliation permanent trueups?: Relmada Therapeutics, Inc. (RLMD) reported effective income tax rate reconciliation permanent trueups of -2.3% in Q4 2024.
What does effective income tax rate reconciliation permanent trueups mean?: This captures the percentage impact of permanent tax differences that do not reverse over time, such as specific tax credits or non-taxable income items. It helps explain the structural divergence between the statutory tax rate and the effective tax rate.